Back to Journals » Journal of Hepatocellular Carcinoma » Volume 2
Original Research
Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,088 | Dovepress* | 9,626+ | 1,044 | 10,670 | |
PubMed Central* | 462 | 72 | 534 | ||
Totals | 10,088 | 1,116 | 11,204 | ||
*Since 22 June 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar